CLINICAL RESEARCH: HEART FAILURE: EDITORIAL COMMENT
Depression: are we ignoring an important comorbidity in heart failure?*
Christopher M. O'Connor, MD, FACC ,* and
Karen E. Joynt, MD
Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
* Reprint requests and correspondence: Dr. Christopher M. O'Connor, Box 3356 Medical Center, Durham, North Carolina 27710, USA.
oconn002{at}mc.duke.edu
Approximately 5 million Americans are currently living with heart failure (HF), and 550,000 new cases are diagnosed yearly (1,2). Patients with HF demonstrate a poor quality of life compared with patients who have other chronic diseases, scoring poorly on measures of physical function, emotional well-being, and overall social function (3,4). Studies have shown that patients with HF have high rates of depression compared with the general population; in addition, depression may confer a negative prognostic impact when present in HF patients, with an increased risk of both rehospitalization and mortality (5–12).
In this issue of the Journal, Gottlieb et al. (13) report the results of a study investigating the prevalence of depression in a cohort of outpatients with HF. One hundred fifty-five patients were enrolled, and they completed assessments, including the Medical Outcomes Study Short Form, the Minnesota Living with Heart Failure Questionnaire, and the Beck Depression Inventory. The authors found that nearly one-half (48%) of the patients were depressed. Depressed patients tended to be younger, and women were more likely to be depressed than men; white men were more likely to be depressed than black men. Depressed patients scored significantly worse on quality of life measurements than patients who were not depressed.
This study is important because it extends our knowledge about the prevalence of depression in HF to the outpatient population. The authors should be commended for focusing on this population, about whom considerably less is known than the inpatient. Furthermore, given that patients spend the vast majority of their time away from the hospital and interact with medical providers primarily at clinic appointments, this represents a more real-world dataset than one composed entirely of inpatients. A limitation to this study, however, is that it is a cross-sectional glimpse; we have no information about the course of patients' depression or cardiac health and no longitudinal data to correlate depression with prognosis.
In the past five years, eight studies have reported on the prevalence of depression in HF. Reported prevalence rates have ranged from 11% to 25% for outpatients and 35% to 70% for inpatients (5–12). In contrast, 5% to 10% of the general population meets the criteria for depression (14). The wide range of prevalence rates across studies of HF patients is likely due to the use of different diagnostic instruments and the inclusion of different patient populations in terms of age, gender, and disease severity. For example, depression may be more common in women with HF (5,10,11,15) and in patients with more severe disease or worse physical symptoms (6,14–16).
What remains largely conjecture, however, is why HF patients display such a markedly elevated prevalence of depression. Some researchers believe that the connection may lie in shared pathophysiology (for review, see reference 17). Neurohormonal activation (18), rhythm disturbances (19), inflammation (20), and hypercoagulability (21) may all play a role in the development, progression, and outcomes of HF. Interestingly, each of these pathologic states are also seen in depressed patients (22–25). This suggests that physiologic states brought on by depression might hasten the development of HF and worsen prognosis for established HF or that a single underlying factor might impact both depression and HF. Psychosocial factors may also contribute; for example, depression is associated with medical noncompliance, a higher prevalence of smoking, and lower levels of social support, each of which have been correlated with worse outcomes in HF (17).
It is even more unclear why patients with HF and depression are not more often treated for their depression. As Gottlieb et al. (13) point out, addressing depression in HF patients represents a prime opportunity to truly improve these patients' quality of life. However, only 7% of the patients in this study were taking an antidepressant. Depression commonly goes undiagnosed; some research suggests that 30% to 50% of cases in the general population are never detected by a medical professional (26–29). Patients may be unwilling to disclose emotional distress to their physicians for fear of being stigmatized with the label of mental illness because they believe their feelings are part of their medical illness or because they don't want a psychiatric diagnosis recorded in their medical record (29,30). Physicians may not address depression because they have not been adequately trained to recognize both typical and atypical depressive symptoms, because of time constraints in high-volume settings, or because they do not know how to best treat the condition. It is also important to recognize the difficulty inherent in diagnosing depression in the context of a disease with symptoms that mimic depression, particularly in the older population (31,32). Heart failure often is associated with fatigue, malaise, and insomnia (3), whereas depression is characterized by fatigue, insomnia, low mood, loss of interest in usual activities, weight loss or gain, feelings of worthlessness, and decreased ability to concentrate (29,33). However, it is crucial that both clinicians and patients realize that the presence of major depression is not a standard part of living with HF. Although feeling upset about having a serious disease like HF may be nearly universal, major depression is not a normal reaction to illness and should be recognized as the disabling, chronic, and treatable condition that it is.
However, there remains a paucity of information regarding safe and efficacious treatment of depression in patients with HF. For example, the recent Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) trial showed that nonpharmacologic strategies in the treatment of depression in patients who suffered a myocardial infarction may not be efficacious (34), and the Montreal Heart Attack Readjustment trial (M-HART) suggested that nonpharmacologic treatment of stress in patients who suffered a myocardial infarction could even be harmful (35). Pharmacologic therapy remains controversial as well; tricyclic antidepressants are known to affect the cardiac system (36), whereas selective serotonin reuptake inhibitors have not been systematically studied in the HF population. The recent Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART), a randomized trial of sertraline in depressed patients with acute coronary syndrome, demonstrated that the treatment of depression can be accomplished without increasing worrisome complications or cardiovascular events (37). Little is known, however, about treatment in patients with HF. The ongoing Sertraline AntiDepressant Heart Attack Randomized Trial in Heart Failure (SADHART-HF), funded by the National Institutes of Mental Health, will give clinicians important data regarding the safety and efficacy of pharmacologic treatment for depression in patients with HF.
The increased prevalence of depression seen in patients with HF is now well established. What remains is to determine why this is the case in the hopes of eventually being able to target treatment at the true root of the problem. In the meantime, HF patients should be screened for depression and treated when depression is found to be present. In this way, we can help improve patients' quality of life and potentially improve long-term outcomes.
 |
Footnotes
|
|---|
* Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. 
|
References
|
|---|
1. American Heart Association. Heart Disease and Stroke Statistics—2003 Update. Dallas, TX: American Heart Association; 2002.
2. Masoudi FA, Havranek EP, Krumholz HM. The burden of chronic congestive heart failure in older persons: Magnitude and implications for policy and research. Heart Fail Rev. 2002;7:9–16[CrossRef][Medline]
3. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables. Heart. 2002;87:235–241[Abstract/Free Full Text]
4. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur Heart J. 2002;23:1867–1876[Abstract/Free Full Text]
5. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849–1856[Abstract/Free Full Text]
6. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20:29–43[CrossRef][Medline]
7. Faris R, Purcell H, Henein MY, Coats AJ. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail. 2002;4:541–551[CrossRef][Medline]
8. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study. Int J Psychiatry Med. 1999;29:311–326[CrossRef][Medline]
9. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999;84:348–350[CrossRef][Medline]
10. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38:199–205[Abstract/Free Full Text]
11. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003;65:119–128[Abstract/Free Full Text]
12. Turvey CL, Schultz K, Arndt S, Wallace RB, Herzog R. Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc. 2002;50:2003–2008[CrossRef][Medline]
13. Gottlieb SS, Khatta M, Friedmann E, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004;43:1542–9.
14. American Psychiatric Association. Let's Talk Facts About Depression. Washington, DC: American Pyschiatric Association; 1998.
15. Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med. 1998;28:273–291[Medline]
16. Friedman MM, Griffin JA. Relationship of physical symptoms and physical functioning to depression in patients with heart failure. Heart Lung. 2001;30:98–104[CrossRef][Medline]
17. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic connection between depression and heart failure. J Cardiac Fail 2004. In Press.
18. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: Diagnostic, prognostic and therapeutic perspectives. Clin Physiol. 2001;21:661–672[CrossRef][Medline]
19. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Circulation. 1998;98:1510–1516[Abstract/Free Full Text]
20. Mann DL. Inflammatory mediators and the failing heart: Past, present, and the foreseeable future. Circ Res. 2002;91:988–998[Abstract/Free Full Text]
21. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: Effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation. 2001;103:1746–1751[Abstract/Free Full Text]
22. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Psychiatr Clin North Am. 1998;21:293–307[CrossRef][Medline]
23. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140:77–83[CrossRef][Medline]
24. Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med. 2000;62:601–605[Abstract/Free Full Text]
25. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63:531–544[Abstract/Free Full Text]
26. Ormel J, Koeter MW, van den Brink W, van de Willige G. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry. 1991;48:700–706[Abstract/Free Full Text]
27. Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med. 1995;4:99–105[Abstract/Free Full Text]
28. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272:1749–1756[Abstract/Free Full Text]
29. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569–580[CrossRef][Medline]
30. Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: What is the breadth and depth of the problem? J Clin Psychiatry. 1999;60(Suppl 7):4–9
31. Alexopoulos GS, Borson S, Cuthbert BN, et al. Assessment of late life depression. Biol Psychiatry. 2002;52:164–174[CrossRef][Medline]
32. Charlson M, Peterson JC. Medical comorbidity and late life depression: What is known and what are the unmet needs? Biol Psychiatry. 2002;52:226–235[CrossRef][Medline]
33. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439–445[CrossRef][Medline]
34. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The enhancing recovery in coronary heart disease patients (enrichd) randomized trial. JAMA. 2003;289:3106–3116[Abstract/Free Full Text]
35. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet. 1997;350:473–479[CrossRef][Medline]
36. Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry. 1981;38:815–820[Abstract/Free Full Text]
37. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709[Abstract/Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
S. A. Thomas, D. W. Chapa, E. Friedmann, C. Durden, A. Ross, M. C. Y. Lee, and H.-J. Lee
Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment
Crit. Care Nurse,
April 1, 2008;
28(2):
40 - 55.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Azevedo, P. Bettencourt, F. Frioes, M. Alvelos, C. Abreu-Lima, H.-W. Hense, and H. Barros
Depressive Symptoms and Heart Failure Stages
Psychosomatics,
February 1, 2008;
49(1):
42 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Holzapfel, C. Zugck, T. Muller-Tasch, B. Lowe, B. Wild, D. Schellberg, M. Nelles, A. Remppis, H. Katus, W. Herzog, et al.
Routine Screening for Depression and Quality of Life in Outpatients With Congestive Heart Failure
Psychosomatics,
April 1, 2007;
48(2):
112 - 116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Lesman-Leegte, T. Jaarsma, R. Sanderman, G. Linssen, and D. J. van Veldhuisen
Depressive symptoms are prominent among elderly hospitalised heart failure patients
Eur J Heart Fail,
October 1, 2006;
8(6):
634 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. G. Koenig, J. Vandermeer, A. Chambers, L. Burr-Crutchfield, and J. L. Johnson
Comparison of Major and Minor Depression in Older Medical Inpatients With Chronic Heart and Pulmonary Disease
Psychosomatics,
August 1, 2006;
47(4):
296 - 303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. G. Koenig
Depression outcome in inpatients with congestive heart failure.
Arch Intern Med,
May 8, 2006;
166(9):
991 - 996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Fauchier
Depression and heart failure
J. Am. Coll. Cardiol.,
December 7, 2004;
44(11):
2253 - 2254.
[Full Text]
[PDF]
|
|
|
|
Top
References